Literature DB >> 3733084

Oral cefuroxime axetil compared with oral ampicillin in treating acute uncomplicated gonorrhoea.

T M Wanas, P E Williams.   

Abstract

The efficacy and tolerance of single oral doses of cefuroxime axetil (1.5 g) were compared with oral ampicillin (3 g) for treating acute gonococcal urethritis in 110 men and 30 women. Each dose was given with 1 g probenecid. Of the 62 assessable patients who received ampicillin, two failed to respond to treatment. Of 67 assessable patients who received cefuroxime axetil, one failed to respond. Pencillinase producing strains of Neisseria gonorrhoeae were isolated from five patients; one received ampicillin and failed to respond, whereas the other four received cefuroxime axetil and three were cured. A single oral dose of 1.5 g cefuroxime axetil with 1 g probenecid seemed to be an effective treatment for acute gonococcal urethritis, especially for penicillin resistant strains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733084      PMCID: PMC1011953          DOI: 10.1136/sti.62.4.221

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  7 in total

1.  Emergence in the Netherlands of penicillinase-producing gonococci carrying "Africa" plasmid in combination with transfer plasmid.

Authors:  J D van Embden; B van Klingeren; M Dessens-Kroon; L J van Wijngaarden
Journal:  Lancet       Date:  1981-04-25       Impact factor: 79.321

2.  Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission.

Authors:  J A McCutchan; M W Adler; J R Berrie
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

3.  Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.

Authors:  S M Harding; P E Williams; J Ayrton
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

4.  Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections.

Authors:  H A Verbrugh; R Peters; M Rozenberg-Arska; P K Peterson; J Verhoef
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

5.  Clinical experience in the use of cefuroxime in gonorrhoea.

Authors:  W Fowler; G Rahim; J D Brown
Journal:  Br J Vener Dis       Date:  1978-12

6.  Cefuroxime compared with penicillin for the treatment of gonorrhea.

Authors:  G D Morrison; A J Evans; H W Haskins; N M Lewis; G H Seale; E Mayall; B M Mullinger
Journal:  Sex Transm Dis       Date:  1980 Oct-Dec       Impact factor: 2.830

7.  Comparison of cefuroxime and penicillin in the treatment of uncomplicated gonorrhea.

Authors:  J G Lossick; S E Thompson; M P Smeltzer
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

  7 in total
  7 in total

1.  Cefuroxime axetil to treat gonorrhea.

Authors:  R P Das; K Jones; A J Robinson; D J Timmins
Journal:  Genitourin Med       Date:  1988-12

Review 2.  Cefuroxime axetil: an updated review of its use in the management of bacterial infections.

Authors:  L J Scott; D Ormrod; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.

Authors:  E M Thorpe; J R Schwebke; E W Hook; A Rompalo; W M McCormack; K L Mussari; G C Giguere; J J Collins
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 4.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

5.  Clinical comparison of single-oral-dose cefuroxime axetil and amoxicillin with probenecid for uncomplicated gonococcal infections in women.

Authors:  L M Baddour; R S Gibbs; G Mertz; D M Cocchetto; R C Noble
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 6.  Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

7.  Cefuroxime axetil (ceftin): a brief review.

Authors:  R D Leder; D S Carson
Journal:  Infect Dis Obstet Gynecol       Date:  1997
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.